A research team led by scientists at the University of California, Riverside, has outlined how the Zika virus, which constituted an epidemic threat in 2016, suppresses the immune system of its host. The Zika virus, or ZIKV, spreads through mosquito bites and sexual intercourse. Currently, no approved vaccine or antivirals...

Over the past few years, biochemist John Jefferson Perry at the University of California, Riverside, has collaborated on a number of projects with Atomwise Inc., a company that uses artificial intelligence, or AI, for drug discovery. Now Perry and the company have formed a joint venture called Theia Biosciences. Perry’s...

NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors

UC Riverside research is supported by a four-year grant worth more than $1.2 million

UC Riverside-led study could lead to the development of drugs that target liver and other cancers

UC Riverside and City of Hope awarded Department of Defense grants for the collaborative project

UC Riverside-led study offers important information for understanding “de novo DNA methylation"